Clinical Trial Update: An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

View source ↗

Summary

An observational study evaluating participants with Type 3 von Willebrand disease receiving prophylactic standard-of-care treatment; recruitment is currently on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease Type

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Von Willebrand Disease, Type 3 | Status: RECRUITING